Nanomedicine Market, By Indication (Clinical Oncology, Infectious Diseases, Clinical Cardiology and Orthopedics), By Molecule Type (Nanoparticles, Nanoshells, Nanotubes and Nanodevices), By Application (Therapeutics, In-vitro Diagnostics, Drug Delivery, In-vivo Imaging and Implants), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Nanomedicine Market size was valued at USD 180,905.6 Million in 2022, expanding at a CAGR of 10.9% from 2023 to 2030.
Nanomedicine is the application of nanotechnology to achieve innovation in healthcare. It uses the properties developed by a material at its nonmetric scale 10-9 m which often differ in terms of physics, chemistry, or biology from the same material at a bigger scale. Nanomedicine offers the potential to provide early detection and prevention, as well as significantly enhance diagnosis, therapy, and follow-up for a wide range of diseases, including cancer. Overall, numerous Nanomedicine items are currently in clinical trials, spanning all main disorders such as cardiovascular, neurological, musculoskeletal, and inflammatory. Nanomedicine, which enables advancements in all sectors of healthcare, now accounts for over 80 marketed items, ranging from nano-delivery and pharmaceutical to medical imaging, diagnostics, and biomaterials.
Nanomedicine Market- Market Dynamics
- Rising advancing technologies for drug delivery and Growing investment in healthcare facilities are expected to propel market demand
Nanotechnology provides medications to be delivered to the exact recognition where they are needed, increasing therapy effectiveness. Nanoparticle drug delivery systems, nano-encapsulation, and nanoscale drug carriers are among the technologies being researched to improve the precision, control, and safety of drug delivery. As governments and commercial entities around the world boost their investment in healthcare infrastructure, sophisticated treatment techniques such as Nanomedicine are becoming more popular. Latest OECD estimates point to average health expenditure growth of 5% in 2020, driven by the exceptionally high growth in spending by government and compulsory schemes (+8.1%) in response to the additional need to address the COVID-19 pandemic. Recent developments in nanotechnology provide enormous opportunities for the development of new Nanomedicine applications. Continuous research and development can result in advancements in illness treatment and prevention. However, the development and production of nanoparticles for medical use can be expensive. These high costs can make Nanomedicine products less accessible, especially in developing and underprivileged regions.
Nanomedicine Market- Key Insights
- As per the analysis shared by our research analyst, the global Nanomedicine market is estimated to grow annually at a CAGR of around 10.9% over the forecast period (2023-2030)
- The Nanomedicine industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
- Based on Indication segmentation, Clinical Oncology was predicted to show maximum market share in the year 2022
- Based on Molecular type segmentation, Nanoparticles were the leading type in 2022
- Based on Application segmentation, drug delivery was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Nanomedicine Market- Segmentation Analysis:
The Global Nanomedicine Market is segmented on the basis of Indication, Molecular type Application, and Region.
The market is divided into three categories based on Indication: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, and Others. Clinical Oncology is expected to dominate the market growth. Clinical oncology, the research, and cancer treatment is one of the key sectors where Nanomedicine has a substantial influence.
The market is divided into four categories based on Molecule Type: Nanoparticles, Nanoshells, Nanotubes, and Nanodevices. Nanoparticles dominate the market and are likely to maintain their dominance during the forecast period. As a subfield of medicine that uses nanoparticles to prevent and treat diseases, Nanomedicine has been showing remarkable potential for transforming healthcare.
The market is divided into four categories based on Application: Therapeutics, In-vitro Diagnostics, Drug Delivery, In-vivo Imaging, and Implants. The drug delivery segment dominates the market. The application of Nanomedicine in drug delivery is one of the most promising areas of healthcare.
Nanomedicine Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Nanomedicine Market. Growing awareness of the prospective benefits of nanotechnology in healthcare, a surge in chronic and life-threatening diseases, and a population that is aging are all fueling up demand for Nanomedicine in North America. According to the CDC, 90% of the nation’s USD3.8 trillion per year healthcare costs can be attributed to people with chronic diseases and mental health conditions. A recent Partnership to Fight Chronic Disease publication determined that treatment of the seven most common chronic diseases, coupled with productivity losses, will cost the U.S. economy USD2 trillion dollars annually USD8,600 per person, by 2030. Europe and Asia Pacific region are expected to drive market growth in the forecast period, due to the availability of advanced healthcare facilities with trained medical professionals, a rise in the number of R&D activities along with the large presence of key players.
Nanomedicine Market- Competitive Landscape:
The Nanomedicine Market is a rapidly growing emerging area with rising demand worldwide driven by the increasing prevalence of chronic diseases, aging populations, and technological improvements. Companies are heavily investing in R&D in order to develop revolutionary Nanomedicine solutions. The competitive advantage is based on technological innovation and the efficacy of developed items. Many companies are entering into partnerships and collaborations to reduce R&D expenses and advance product development and approval. These collaborations frequently involve the exchange of expertise and resources, which can help businesses obtain a competitive advantage. For example, on 21 Oct, 2022, GE Healthcare and Accuray Incorporated announced nowadays global commercial collaboration agreement to develop solutions that will allow more healthcare teams across the world to adapt patients\' care at every point of their treatment path. The two companies will make available a comprehensive offering that combines GE Healthcare\'s precision diagnostic tools and Accuray Incorporated\'s innovative radiation therapy delivery capabilities to advance radiation therapy practice and help patients diagnosed with cancer gain personalized care.
Recent Developments:
- On 9 January 2023, A novel combination of artificial intelligence and production techniques could change the future of Nanomedicine, according to Cornell researchers using a new USD3 million grant from the National Science Foundation to revolutionize how polymer nanoparticles are manufactured.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NANOMEDICINE MARKET KEY PLAYERS
- Abbott Laboratories
- CombiMatrix Corporation
- Celgene Corporation
- Nanospectra Biosciences, Inc.
- GE Healthcare
- Johnson & Johnson Services, Inc.
- Mallinckrodt Pharmaceuticals
- Merck & Co., Inc.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Arrowhead Pharmaceuticals, Inc.
GLOBAL NANOMEDICINE MARKET, BY INDICATION
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopedics
- Others
GLOBAL NANOMEDICINE MARKET, BY MOLECULE TYPE
- Nanoparticles
- Metal & Metal Oxide Nanoparticles
- Liposomes
- Polymers & Polymer Drug Conjugates
- Hydrogel Nanoparticles
- Dendrimers
- Inorganic Nanoparticles
- Nanoshells
- Nanotubes
- Nanodevices
GLOBAL NANOMEDICINE MARKET, BY APPLICATION
- Therapeutics
- In-vitro Diagnostics
- Drug Delivery
- In-vivo Imaging
- Implants
GLOBAL NANOMEDICINE MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Nanomedicine Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Nanomedicine Market Snippet by Indication
2.1.2. Nanomedicine Market Snippet by Molecule Type
2.1.3. Nanomedicine Market Snippet by Application
2.1.4. Nanomedicine Market Snippet by Country
2.1.5. Nanomedicine Market Snippet by Region
2.2. Competitive Insights
3. Nanomedicine Key Market Trends
3.1. Nanomedicine Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Nanomedicine Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Nanomedicine Market Opportunities
3.4. Nanomedicine Market Future Trends
4. Nanomedicine Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Nanomedicine Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Nanomedicine Market Landscape
6.1. Nanomedicine Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Nanomedicine Market – By Indication
7.1. Overview
7.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
7.1.2. Clinical Oncology
7.1.3. Infectious Diseases
7.1.4. Clinical Cardiology
7.1.5. Orthopedics
7.1.6. Others
8. Nanomedicine Market – By Molecule Type
8.1. Overview
8.1.1. Segment Share Analysis, By Molecule Type, 2022 & 2030 (%)
8.1.2. Nanoparticles
8.1.2.1. Metal & Metal Oxide Nanoparticles
8.1.2.2. Liposomes
8.1.2.3. Polymers & Polymer Drug Conjugates
8.1.2.4. Hydrogel Nanoparticles
8.1.2.5. Dendrimers
8.1.2.6. Inorganic Nanoparticles
8.1.3. Nanoshells
8.1.4. Nanotubes
8.1.5. Nanodevices
9. Nanomedicine Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
9.1.2. Therapeutics
9.1.3. In-vitro Diagnostics
9.1.4. Drug Delivery
9.1.5. In-vivo Imaging
9.1.6. Implants
10. Nanomedicine Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Nanomedicine Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Nanomedicine Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Nanomedicine Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Nanomedicine Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Nanomedicine Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Nanomedicine Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.2. CombiMatrix Corporation
11.2.3. Celgene Corporation
11.2.4. Nanospectra Biosciences, Inc.
11.2.5. GE Healthcare
11.2.6. Johnson & Johnson Services, Inc.
11.2.7. Mallinckrodt Pharmaceuticals
11.2.8. Merck & Co., Inc.
11.2.9. Pfizer, Inc.
11.2.10. Teva Pharmaceutical Industries Ltd.
11.2.11. Arrowhead Pharmaceuticals, Inc.
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
